Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 11.70
+0.30 (2.63%)
At close: Feb 5, 2026
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 241.6 million as of February 5, 2026. Its market cap has decreased by -65.08% in one year.
Market Cap
241.60M
Enterprise Value
567.90M
Revenue
300.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.70
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has increased from 205.10M to 241.60M, an increase of 17.80%. That is a compound annual growth rate of 2.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 235.40M | -35.23% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mendus AB | 309.84M |
| Lipum AB | 294.85M |
| Intervacc AB | 293.78M |
| Bio-Works Technologies AB | 278.39M |
| Xintela AB | 251.49M |
| Elicera Therapeutics AB | 248.99M |
| AlzeCure Pharma AB | 228.68M |
| Xbrane Biopharma AB | 204.28M |